Cargando…

Dynamiceuticals: The Next Stage in Personalized Medicine

The surge in the interest in personalized medicine necessitates a corresponding rational approach for implementing such individualized therapies. Dynamiceuticals represents a natural extension of the Pharmaceutical and Electroceutical fields, where the precise determination of the dynamical regimes...

Descripción completa

Detalles Bibliográficos
Autor principal: Perez Velazquez, Jose L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461286/
https://www.ncbi.nlm.nih.gov/pubmed/28638319
http://dx.doi.org/10.3389/fnins.2017.00329
_version_ 1783242307611394048
author Perez Velazquez, Jose L.
author_facet Perez Velazquez, Jose L.
author_sort Perez Velazquez, Jose L.
collection PubMed
description The surge in the interest in personalized medicine necessitates a corresponding rational approach for implementing such individualized therapies. Dynamiceuticals represents a natural extension of the Pharmaceutical and Electroceutical fields, where the precise determination of the dynamical regimes of the pathophysiology will guide to devise therapies that ameliorate the pathology in a well-controlled manner, thus being precisely tailored toward the implementation of individualized medicine. This approach foretells to lessen side-effects and achieve superior efficacy as compared with current trial-and-error or open-loop strategies. But does the current state of knowledge and technology allow this scheme to offer what it claims?
format Online
Article
Text
id pubmed-5461286
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54612862017-06-21 Dynamiceuticals: The Next Stage in Personalized Medicine Perez Velazquez, Jose L. Front Neurosci Neuroscience The surge in the interest in personalized medicine necessitates a corresponding rational approach for implementing such individualized therapies. Dynamiceuticals represents a natural extension of the Pharmaceutical and Electroceutical fields, where the precise determination of the dynamical regimes of the pathophysiology will guide to devise therapies that ameliorate the pathology in a well-controlled manner, thus being precisely tailored toward the implementation of individualized medicine. This approach foretells to lessen side-effects and achieve superior efficacy as compared with current trial-and-error or open-loop strategies. But does the current state of knowledge and technology allow this scheme to offer what it claims? Frontiers Media S.A. 2017-06-07 /pmc/articles/PMC5461286/ /pubmed/28638319 http://dx.doi.org/10.3389/fnins.2017.00329 Text en Copyright © 2017 Perez Velazquez. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Perez Velazquez, Jose L.
Dynamiceuticals: The Next Stage in Personalized Medicine
title Dynamiceuticals: The Next Stage in Personalized Medicine
title_full Dynamiceuticals: The Next Stage in Personalized Medicine
title_fullStr Dynamiceuticals: The Next Stage in Personalized Medicine
title_full_unstemmed Dynamiceuticals: The Next Stage in Personalized Medicine
title_short Dynamiceuticals: The Next Stage in Personalized Medicine
title_sort dynamiceuticals: the next stage in personalized medicine
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461286/
https://www.ncbi.nlm.nih.gov/pubmed/28638319
http://dx.doi.org/10.3389/fnins.2017.00329
work_keys_str_mv AT perezvelazquezjosel dynamiceuticalsthenextstageinpersonalizedmedicine